202 related articles for article (PubMed ID: 27409831)
1. Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: a PET imaging and metabolomics-mass-spectrometry study.
Gaglio D; Valtorta S; Ripamonti M; Bonanomi M; Damiani C; Todde S; Negri AS; Sanvito F; Mastroianni F; Di Campli A; Turacchio G; Di Grigoli G; Belloli S; Luini A; Gilardi MC; Colangelo AM; Alberghina L; Moresco RM
Oncotarget; 2016 Aug; 7(32):52017-52031. PubMed ID: 27409831
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth.
Gaglio D; Metallo CM; Gameiro PA; Hiller K; Danna LS; Balestrieri C; Alberghina L; Stephanopoulos G; Chiaradonna F
Mol Syst Biol; 2011 Aug; 7():523. PubMed ID: 21847114
[TBL] [Abstract][Full Text] [Related]
3. Combining ATR suppression with oncogenic Ras synergistically increases genomic instability, causing synthetic lethality or tumorigenesis in a dosage-dependent manner.
Gilad O; Nabet BY; Ragland RL; Schoppy DW; Smith KD; Durham AC; Brown EJ
Cancer Res; 2010 Dec; 70(23):9693-702. PubMed ID: 21098704
[TBL] [Abstract][Full Text] [Related]
4. Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance.
Lim JKM; Delaidelli A; Minaker SW; Zhang HF; Colovic M; Yang H; Negri GL; von Karstedt S; Lockwood WW; Schaffer P; Leprivier G; Sorensen PH
Proc Natl Acad Sci U S A; 2019 May; 116(19):9433-9442. PubMed ID: 31000598
[TBL] [Abstract][Full Text] [Related]
5. Disruption of redox homeostasis for combinatorial drug efficacy in
Gaglio D; Bonanomi M; Valtorta S; Bharat R; Ripamonti M; Conte F; Fiscon G; Righi N; Napodano E; Papa F; Raccagni I; Parker SJ; Cifola I; Camboni T; Paci P; Colangelo AM; Vanoni M; Metallo CM; Moresco RM; Alberghina L
Cancer Metab; 2020; 8():22. PubMed ID: 33005401
[TBL] [Abstract][Full Text] [Related]
6. Altered detoxification status and increased resistance to oxidative stress by K-ras transformation.
Recktenwald CV; Kellner R; Lichtenfels R; Seliger B
Cancer Res; 2008 Dec; 68(24):10086-93. PubMed ID: 19074874
[TBL] [Abstract][Full Text] [Related]
7. Four Key Steps Control Glycolytic Flux in Mammalian Cells.
Tanner LB; Goglia AG; Wei MH; Sehgal T; Parsons LR; Park JO; White E; Toettcher JE; Rabinowitz JD
Cell Syst; 2018 Jul; 7(1):49-62.e8. PubMed ID: 29960885
[TBL] [Abstract][Full Text] [Related]
8. Oligonucleotide treatment of ras-induced tumors in nude mice.
Wickstrom E
Mol Biotechnol; 2001 May; 18(1):35-55. PubMed ID: 11439698
[TBL] [Abstract][Full Text] [Related]
9. The greedy nature of mutant RAS: a boon for drug discovery targeting cancer metabolism?
Lv J; Wang J; Chang S; Liu M; Pang X
Acta Biochim Biophys Sin (Shanghai); 2016 Jan; 48(1):17-26. PubMed ID: 26487443
[TBL] [Abstract][Full Text] [Related]
10. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
[TBL] [Abstract][Full Text] [Related]
11. The role of autophagy in cytotoxicity induced by new oncogenic B-Raf inhibitor UI-152 in v-Ha-ras transformed fibroblasts.
Ahn JH; Ahn SK; Lee M
Biochem Biophys Res Commun; 2012 Jan; 417(2):857-63. PubMed ID: 22206679
[TBL] [Abstract][Full Text] [Related]
12. Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes.
Bradley MO; Kraynak AR; Storer RD; Gibbs JB
Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5277-81. PubMed ID: 3523488
[TBL] [Abstract][Full Text] [Related]
13. T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.
Ray DB; Merrill GA; Brenner FJ; Lytle LS; Lam T; McElhinney A; Anders J; Rock TT; Lyker JK; Barcus S; Leslie KH; Kramer JM; Rubenstein EM; Pryor Schanz K; Parkhurst AJ; Peck M; Good K; Granath KL; Cifra N; Detweiler JW; Stevens L; Albertson R; Deir R; Stewart E; Wingard K; Richardson MR; Blizard SB; Gillespie LE; Kriley CE; Rzewnicki DI; Jones DH
Exp Cell Res; 2016 Jan; 340(1):1-11. PubMed ID: 26254261
[TBL] [Abstract][Full Text] [Related]
14. UHPLC-MS-based metabolomics analysis on mice bearing neoplasm (H22) for hispidulin.
Li F; Li X; Miao Y; Shan C; Yuan F; Ma C; Wang Q; Chen J; Chen Y
J Pharm Biomed Anal; 2016 Jun; 125():310-8. PubMed ID: 27077962
[TBL] [Abstract][Full Text] [Related]
15. A Proteomic approach for protein-profiling the oncogenic ras induced transformation (H-, K-, and N-Ras) in NIH/3T3 mouse embryonic fibroblasts.
Kim S; Lee YZ; Kim YS; Bahk YY
Proteomics; 2008 Aug; 8(15):3082-93. PubMed ID: 18601226
[TBL] [Abstract][Full Text] [Related]
16. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry.
Hirayama A; Kami K; Sugimoto M; Sugawara M; Toki N; Onozuka H; Kinoshita T; Saito N; Ochiai A; Tomita M; Esumi H; Soga T
Cancer Res; 2009 Jun; 69(11):4918-25. PubMed ID: 19458066
[TBL] [Abstract][Full Text] [Related]
17. Metabolic profiling of gemcitabine- and paclitaxel-treated immortalized human pancreatic cell lines with K-RAS
Todaka A; Umehara R; Sasaki K; Serizawa M; Urakami K; Kusuhara M; Yamaguchi K; Yasui H
Biomed Res; 2017; 38(1):29-40. PubMed ID: 28239030
[TBL] [Abstract][Full Text] [Related]
18. Different patterns of gene expression in ras-resistant and ras-sensitive cells.
Tuck AB; Wilson SM; Khokha R; Chambers AF
J Natl Cancer Inst; 1991 Apr; 83(7):485-91. PubMed ID: 1848638
[TBL] [Abstract][Full Text] [Related]
19. Impairment of mitochondrial respiration in mouse fibroblasts by oncogenic H-RAS(Q61L).
Yang D; Wang MT; Tang Y; Chen Y; Jiang H; Jones TT; Rao K; Brewer GJ; Singh KK; Nie D
Cancer Biol Ther; 2010 Jan; 9(2):122-33. PubMed ID: 19923925
[TBL] [Abstract][Full Text] [Related]
20. Glutamine deprivation induces abortive s-phase rescued by deoxyribonucleotides in k-ras transformed fibroblasts.
Gaglio D; Soldati C; Vanoni M; Alberghina L; Chiaradonna F
PLoS One; 2009; 4(3):e4715. PubMed ID: 19262748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
